A Robust, Automated Karl Fischer Titration System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

A Robust, Automated Karl Fischer Titration System
The authors developed a robust, automated system to conduct Karl Fischer moisture assays for lyophilized products.


Pharmaceutical Technology
Volume 33, Issue 11, pp. 52-60

The instrument control software offers the users a limited number of choices. The manual "Control" screen allows the operator to activate certain functions such as the titration-cell wash routine, open and close the titration-cell cap, move the robot arm grippers, control the balance door, and operate the decapping station gripper. The operator thus has sufficient control to handle routine maintenance such as cleaning the titration cell and removing sample tubes that were left in the system after a critical error or an emergency stop. Advanced functions such as control of the robot-arm movements are disabled for safety reasons and can only be accessed through a password-protected administrator login.

The "Run Standards" screen allows the operator to perform titer determination using sodium tartrate. The raw data (volume of titrant dispensed) is obtained from the titrator, the sample mass is obtained from the balance and the titer (mg H2O/mL KF reagent) is calculated and stored by the Focus software. Here, a minimum of three replicates are required. The average value is used for all subsequent sample moisture determination.

The "Run Sample" screen allow users to enter the total number of samples to be analyzed and the number of titrations to be performed before the titration cell is washed. These two user-input parameters are the only ones that directly affect system operation. No product-specific methods exist. All samples are handled and analyzed in the same manner. After each moisture determination, the result is sent to the computer and immediately printed on the attached line printer. To simplify system validation, the authors decided not to include the optional 21 CFR Part 11: Electronic Records, Electronic Signature feature, but this functionality could be added in a future software revision if needed.

The "Mock Run" screen is identical to the "Run Sample" screen, with exception that no titration is performed. This mode is used for system demonstration and training purposes.

System testing

The system was subjected to comprehensive tests, including hardware error checking and recovery. No major difficulties were encountered. Operational testing was simplified by the limited number of user input parameters. This section presents the results from the most relevant studies: the moisture determination of active hygroscopic freeze-dried product from a fully loaded sample rack.


Figure 3: The effect of queue time on sample moisture. The squares and dashed line represent Sample Set 1. The circles and solid line represent Sample Set 2. (IMAGE IS COURTESY OF PHILIPPE LAM)
For these studies, the sample queue times (i.e., the time the samples were on the rack awaiting analysis) were recorded. Figure 3 summarizes the results for two sets of samples consisting of two batches of active material lyophilized in 50-cm3 vials. For the second set, analysis was paused after 4.5 h and resumed 17 h later to increase the queue time.

The data show that, for this product, the sample moisture increases in a linear way as a function of queue time. The increase suggests that the samples absorb environmental moisture, most likely from diffusion though the centrifuge tube wall or the cap closure seal. The absolute overhead moisture present in a 15-mL sample tube under typical laboratory ambient conditions of 21 °C and 50 ± 15% relative humidity is approximately 1.4 × 10-4 mg, an insignificant amount. The moisture-ingress rates for the two sets of samples are 0.018 wt%/h and 0.0095 wt %/h, respectively. This behavior is expected and results from the sample-preparation method selected. Although this small amount of moisture ingress seems to be a shortfall, in practice, analysts prepare 10–20 samples at a time, and samples are added only after most of the initial samples have been tested. Hence, the queue time is typically only a few hours. This minor limitation was deemed an acceptable tradeoff for the convenience afforded by an automated system.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
11%
To select process for new products only
25%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here